Inventor · disambiguated record
Lars Linden
Also filed as: LINDEN LARS · LINDEN LARS AAKE · LINDEN LARS AKE
8 granted patents·15 pending applications·141 citations·filing 1998–2022
87Inventor score
Top patents by PatentIndex Score
23 records- 0192US8992932B2Binder-drug conjugates (ADCs) and use thereofSEATTLE GENETICS INC·Filed 2012·Granted Mar 31, 2015·26 cites·12 claims
- 0285US9382305B2Relaxin fusion polypeptides and uses thereofWILMEN ANDREAS·Filed 2012·Granted Jul 5, 2016·20 cites·17 claims
- 0380US9777063B2Neutralizing prolactin receptor antibody Mat3 and its therapeutic useBAYER IP GMBH·Filed 2016·Granted Oct 3, 2017·3 cites·4 claims
- 0480US5997301ATreatment of tooth surfaces and substances thereforFiled 1999·Granted Dec 7, 1999·65 cites·15 claims
- 0576US11260136B2Radio-pharmaceutical complexesBayer Pharma AG·Filed 2017·Granted Mar 1, 2022·1 cites·9 claims
- 0667US2022143229A1Radio-pharmaceutical complexesBayer Pharma AG·Filed 2022·Application pending·0 cites
- 0766US9353186B2Neutralizing prolactin receptor antibody Mat3 and its therapeutic useFREIBERG CHRISTOPH·Filed 2012·Granted May 31, 2016·2 cites·14 claims
- 0861US5915969ATreatment of tooth surfaces and substance thereforFiled 1998·Granted Jun 29, 1999·24 cites·14 claims
- 0961US2015030618A1Novel binder-drug conjugates (adcs) and use thereofSEATTLE GENETICS INC·Filed 2014·Application pending·0 cites
- 1057US2014127240A1Novel Binder-Drug Conjugates (ADCs) and Use of SameLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 1157US2013122024A1New binder-drug conjugates (adcs) and use thereofLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 1256US2013066055A1New binder-drug conjugates (adcs) and use thereofLERCHEN HANS-GEORG·Filed 2012·Application pending·0 cites
- 1356US2016193359A1New binder-drug conjugates (adcs) and use thereofSEATTLE GENETICS INC·Filed 2016·Application pending·0 cites
- 1454US2015246136A1NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAMESEATTLE GENETICS INC·Filed 2015·Application pending·0 cites
- 1551US2017158775A1Anti-c4.4a antibodies and uses thereofBAYER IP GMBH·Filed 2017·Application pending·0 cites
- 1651US2005130260A1Refolded membrane protein in monodisperse formFiled 2003·Application pending·0 cites
- 1747US2014322220A1Anti-FGFR2 Antibodies and Uses ThereofBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 1844US2007031926A1Refolded membrane protein in monodisperse formLINDEN LARS·Filed 2006·Application pending·0 cites
- 1943US11077187B2Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereofOKLAHOMA MED RES FOUND·Filed 2016·Granted Aug 3, 2021·0 cites·17 claims
- 2043US2016237160A1Anti-tweakr antibodies and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2143US2016009776A1Pdgfrbeta-fc fusion proteins and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2242US2014050743A1Binding proteins to inhibitors of coagulation factorsDITTMER FRANK·Filed 2012·Application pending·0 cites
- 2341US2012321619A1Anti-c4.4a antibodies and uses thereofLINDEN LARS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Linden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →